Detalhe da pesquisa
1.
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus.
Blood
; 124(9): 1404-11, 2014 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25027391
2.
Ocular adnexal MALTomas: case series of patients treated with primary radiation.
Clin Adv Hematol Oncol
; 11(4): 209-14, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23604236
3.
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Blood
; 115(13): 2578-85, 2010 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19965662
4.
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia.
Blood
; 113(16): 3673-8, 2009 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19015393
5.
Clinical and laboratory features of myelofibrosis and limitations of current therapies.
Clin Adv Hematol Oncol
; 9(9 Suppl 22): 1-16, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22362131
6.
Harnessing the energy: development of radioimmunotherapy for patients with non-Hodgkin's lymphoma.
Oncologist
; 14 Suppl 2: 4-16, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19819920
7.
Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture.
Transfusion
; 48(12): 2638-44, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18798803
8.
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma.
Clin Cancer Res
; 13(20): 6168-74, 2007 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17947483
9.
Successful treatment of hepatosplenic T-cell lymphoma with ESHAP followed by autologous stem cell transplant.
Clin Adv Hematol Oncol
; 11(2): 109-13, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23598914
10.
Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
Clin Adv Hematol Oncol
; 6(6): 437-45, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18567989
11.
A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma.
Leuk Lymphoma
; 48(1): 39-45, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17325846
12.
Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.
Clin Lymphoma Myeloma
; 7(6): 406-12, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17621406
13.
Emerging treatments for indolent lymphoma.
Clin Adv Hematol Oncol
; 5(5 Suppl 8): 1-9; quiz 11-2, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17637594
14.
Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma.
Mol Clin Oncol
; 6(4): 627-633, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28413681
15.
Re-treatment with I-131 tositumomab in patients with non-Hodgkin's lymphoma who had previously responded to I-131 tositumomab.
J Clin Oncol
; 23(31): 7985-93, 2005 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16204016
16.
Multiple myeloma with multiple extramedullary plasmacytomas.
Clin Adv Hematol Oncol
; 9(8): 630-2, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22236993
17.
CHOP Chemotherapy Followed by Tositumomab and Iodine-131 Tositumomab for Previously Untreated Diffuse Large B-cell Lymphoma.
Clin Lymphoma Myeloma Leuk
; 16(4): 191-6, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26832194
18.
The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma.
Clin Lymphoma
; 6(1): 26-30, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15989703
19.
Intravascular B-cell lymphoma following nodal diffuse large B-cell lymphoma.
Clin Adv Hematol Oncol
; 8(9): 637-41, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21157413
20.
New directions in the therapeutic strategy to improve survival outcomes in patients with non-Hodgkin's lymphoma. Introduction.
Oncologist
; 14 Suppl 2: 1-3, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19819919